IGC Pharma, Inc. (IGC)

NYSE Pharmaceutical Pharmaceutical Preparations SIC: 2834
D
Pipeline Grade

Financial Position (from SEC Filings)

$0.2M
Cash & Equivalents
$1.2M
Quarterly Burn Rate
1 mo
Est. Cash Runway
$27M
Market Cap

Estimated from most recent SEC quarterly filing. View SEC filings

Drug Pipeline (0 Assets)

No drugs indexed yet. Pipeline data is populated from ClinicalTrials.gov and openFDA.

Upcoming Catalysts

DateEventDrug
2026-08-01 Phase2 Readout —

Active Clinical Trials (1)

NCT #TitlePhaseStatusEnrollment
NCT05543681 Clinical Trial on Agitation in Alzheimer's Dementia PHASE2 Recruiting 164

Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.

More Analysis

AI Stock Score

SEC EDGAR fundamental analysis with Claude AI & ChatGPT ratings for IGC.

SEC EDGAR Filings

All SEC filings for IGC Pharma, Inc. on EDGAR.

Full Calendar

View all upcoming FDA catalysts across all biotech companies.